Pulse Therapeutics, Inc. — Form D/A
Pulse Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D amendment with the SEC on 2011-08-01. The offering totals $2.0M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-08-01
- Form: D/A
- Accession: 0001518707-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.6M
- Remaining: $350K
- Investors: 8
- Date of first sale: 2011-04-06
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-158750
Issuer
- Name: Pulse Therapeutics, Inc.
- CIK: 0001518707
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 911 WASHINGTON AVENUE, ST. LOUIS, MO, 63101
- Phone: 314-787-7475
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Amy L Boyet | Executive Officer | St. Louis, MO |
| Rogers M Ritter | Executive Officer | St. Louis, MO |
| Sean Morris | Director | Wildwood, MO |
| Sean Morris | Executive Officer | Wildwood, MO |
| James C Wachtman | Executive Officer | KANSAS CITY, MO |
| Thomas Hillman | Director | Saint Louis, MO |
| Eric Moessinger | Director | San Francisco, CA |
| Thomas J Hillman | Director | Saint Louis, MO |
| PEGGY STOHR | Executive Officer | ST. LOUIS, MO |
| Bevil J Hogg | Director | St. Louis, MO |
| Daniel J Broderick | Director | Durham, NC |
| Eric A Gulve | Director | St. Louis, MO |
| Peggy A Stohr | Executive Officer | St. Louis, MO |
| Sean A Morris | Executive Officer | St. Louis, MO |
| Francis M Creighton | Director | St. Louis, MO |
| Francis M Creighton | Executive Officer | St. Louis, MO |
| Stephen A Wexler | Director | St. Louis, MO |
| PETER S FINLEY | Executive Officer | CLAYTON, MO |
| Rogers A Ritter | Executive Officer | St. Louis, MO |
Other filings by this issuer (4)
More